Topic: life sciences

Subscribe

Subscribe Options (Close)

Topic: life sciences

New with Topic: life sciences

Xconomy posted a blog entry

Arena Loses Merck Collaboration After Clogged-Artery Drug Fails Clinical Trial
Somebody always delivers some bad news on the slow days before Christmas, and this year, it’s Arena Pharmaceuticals. The...

1 day ago

Xconomy - Business + Technology in the Exponential Economy | Topics: National blog..., San Diego, San Diego blog..., Biotech

Xconomy posted a blog entry

HyperMed Files for Chapter 11 Bankruptcy
Burlington, MA-based medical devices firm HyperMed has filed for Chapter 11 bankruptcy and ceased operations, the Boston...

1 day ago

Xconomy - Business + Technology in the Exponential Economy | Topics: Boston, Boston briefs, National..., Life Sciences

Xconomy posted a blog entry

pSivida Shares Boom as Eye Drug Passes Pivotal Trial
Shares of pSivida (NASDAQ: PSDV) rocketed more than 50 percent this morning on some positive clinical trial news. The...

1 day ago

Xconomy - Business + Technology in the Exponential Economy | Topics: Boston, Boston blog..., National blog..., Biotech

Xconomy posted a blog entry

In Development of Bio-Engineered Skin Tissue, Third Try is Charm for Advanced BioHealing
When it comes to commercializing a bio-engineered human skin substitute that could be used to treat diabetic ulcers and other...

2 days ago

Xconomy - Business + Technology in the Exponential Economy | Topics: National blog..., San Diego, San Diego blog..., Life Sciences

Xconomy posted a blog entry

Ambit, Buoyed by Astellas Deal, Attempting Rare Switch from Platform to Drug Developer
Ambit Biosciences made news last Friday when it pulled in $40 million through a partnership with Japan-based Astellas Pharma....

2 days ago

Xconomy - Business + Technology in the Exponential Economy | Topics: National blog..., San Diego, San Diego blog..., Biotech

Xconomy posted a blog entry

Biogen Drops Facet Bid, Aveo Reveals IPO Ambitions, Pfizer Partners with Adimab, & More Boston-Area Life Sciences News
New England’s drug developers and device makers are squeezing in a few more partnerships, acquisitions, financings, and...

2 days ago

Xconomy - Business + Technology in the Exponential Economy | Topics: Boston, Boston blog..., National blog..., Roundup

Xconomy posted a blog entry

The Top Five Disruptive Technologies From the Decade of Genomics
1. The Human Genome Project2. Massively parallel DNA sequencing3. Personalizing therapeutics via companion...

2 days ago

Xconomy - Business + Technology in the Exponential Economy | Topics: Boston Xcon, National, National Xcon, San Diego...

Xconomy posted a blog entry

AVI Biopharma Drug Shows Hint of Effect Against Muscular Dystrophy In Small Study
Bothell, WA-based AVI Biopharma (NASDAQ: AVII) is trying to develop the first treatment to correct an underlying molecular...

2 days ago

Xconomy - Business + Technology in the Exponential Economy | Topics: National blog..., Seattle, Seattle blog..., Biotech

Xconomy posted a blog entry

GI Dynamics Gets European Approval
GI Dynamics has garnered European marketing approval for its temporary intestinal implant for treating Type 2 diabetes and...

2 days ago

Xconomy - Business + Technology in the Exponential Economy | Topics: Boston, Boston briefs, National..., medical...

more...